Eos Energy Enterprises is navigating one of the sharpest short squeezes in the clean-energy storage space — yet with 30% of the float still borrowed, the tension between the bulls who just received a major catalyst and the bears who have been building since April is far from resolved.
The week's story centres on a genuine earnings surprise. Eos reported Q1 EPS of $0.12, demolishing the consensus estimate of -$0.22 — a $0.34 beat. Revenue of $56.96M came in fractionally below the $57.58M estimate, but the company reaffirmed full-year 2026 sales guidance of $300M-$400M. Alongside the results, Eos announced a partnership with Cerberus Capital to launch Frontier Power USA, a dedicated long-duration energy storage platform backed by $250M. The stock initially surged over 30% on the news before giving back some of the move. The prior Q1 earnings event in early May 2026 saw the stock climb 2.5% the following day and 27% over the subsequent five sessions — suggesting the market had already been front-running momentum into this print.
Short positioning heading into the results was extreme. SI % FF has been running at approximately 30-31% of free float for the past three weeks — up sharply from roughly 27.6% at the start of April, as bears steadily built into the price rally. That earlier build happened even as the stock surged 44% over the past month, pointing to a cohort of shorts who remained committed through significant pain. On the day of results, short interest barely budged, edging down just 0.25% on the day to roughly 103 million shares. The ORTEX short score is 71.8 — firmly in elevated territory — and the factor rank for short score puts EOSE in the 3rd percentile of stocks universe-wide, meaning almost no stock carries a more crowded short book. Despite that, the borrow market tells a different story: cost to borrow is running at just 0.80% annualised, essentially at the floor, and availability is well above distressed levels. There is no squeeze pressure in the lending market itself; shorts can hold at near-zero cost.
Options traders have not adopted a particularly defensive posture ahead of or after the print. The put/call ratio is 0.36, almost exactly in line with its 20-day average of 0.355 — a z-score of just 0.35. The 52-week range on the PCR runs from 0.19 to 0.58, and the current reading is unremarkable by any measure. That absence of options-driven hedging demand is notable given how heavily the stock is shorted; it suggests the options crowd is neither strongly bearish nor protecting against a squeeze at current levels.
Analyst sentiment is cautious and has drifted more so over recent months. JP Morgan's Mark Strouse cut his target from $9 to $6 on April 16, maintaining Neutral — the most recent action from a bellwether. B. Riley and Roth Capital both trimmed targets to $6 in late February, also keeping Neutral ratings. Guggenheim downgraded from Buy to Neutral the same week without publishing a fresh target. The mean price target among analysts sits at $8.86 — close to the current $8.10 close — leaving very thin upside on consensus. The Benzinga bull case points to gross margin improvement, a growing data-centre-driven pipeline, and the Cerberus partnership as validating commercial scale. Bears counter that EBITDA has consistently undershot estimates and that competition from established lithium-ion storage remains fierce. Note that some analyst targets above were issued when the stock traded above $15 earlier this year; the post-downgrade reset may not yet fully reflect the Cerberus JV announcement.
Institutional ownership adds an interesting texture. BlackRock added roughly 5 million shares in the most recent reported period to reach a 6.9% stake, and Vanguard added 3.1 million shares. Driehaus Capital — a firm known for momentum-oriented strategies — more than doubled its position, adding 7.7 million shares to hold 4.2% of the company. On the insider side, CEO Joseph Mastrangelo bought approximately 83,900 shares across two transactions in early March at prices between $5.75 and $6.58. A director also bought in the same window. Those purchases, made at prices well below current levels, are now sitting on meaningful gains — a reminder that management loaded up near the lows.
With the earnings catalyst now consumed and the Cerberus announcement digested, what matters next is whether the short base — still at one of the heaviest levels in the market — begins to cover materially, or whether post-result fade draws fresh sellers back in. The next earnings event is scheduled for June 3, leaving only three weeks before positioning is tested again.
See the live data behind this article on ORTEX.
Open EOSE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
